Position in NVS
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$316,887
+$9,249 QoQ
Shares Held
2,022
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,102
of 1,603 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 63%
Shared 17%
None 19%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First County Bank /CT/ holds $14,817,156 across 10 Drug Manufacturers - General names. NVS ranks #10 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
14,610 | $3,676,457 | |
| 2 | MRK |
Merck & Co., Inc.
|
18,788 | $2,414,256 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
15,088 | $1,906,217 | |
| 4 | JNJ |
Johnson & Johnson
|
6,398 | $1,624,899 | |
| 5 | LLY |
ELI LILLY & Co
|
1,319 | $1,582,048 | |
| 6 | AMGN |
Amgen Inc
|
4,058 | $1,469,482 | |
| 7 | BIIB |
Biogen Inc.
|
3,933 | $849,763 | |
| 8 | PFE |
Pfizer Inc
|
23,791 | $572,886 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $316,887 | 2,022 | Shares | Defined | 2026-07-02 | |
| 2026-03-31 | $307,638 | 2,014 | Shares | Defined | 2026-04-03 | |
| 2025-12-31 | $201,565 | 1,462 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $230,062 | 1,794 | Shares | Defined | 2025-10-08 | |
| 2025-06-30 | $208,015 | 1,719 | Shares | Defined | 2025-07-17 | |
| No filing history on record for this holder in this stock. | ||||||